Modrall J G, Nanamori M, Sadoshima J, Barnhart D C, Stanley J C, Neubig R R
Department of Surgery, Dallas Veterans Affairs Medical Center and the University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA.
Am J Physiol Cell Physiol. 2001 Sep;281(3):C801-9. doi: 10.1152/ajpcell.2001.281.3.C801.
ANG II type 1 (AT(1)) receptors respond to sustained exposure to ANG II by undergoing downregulation of absolute receptor numbers. It has been assumed previously that downregulation involves endocytosis. The present study hypothesized that AT(1) receptor downregulation occurs independently of receptor endocytosis or G protein coupling. Mutant AT(1) receptors with carboxy-terminal deletions internalized <5% of radioligand compared with 65% for wild-type AT(1) receptors. The truncated AT(1) receptors retained the ability to undergo downregulation. These data suggest the existence of an alternative pathway to AT(1) receptor degradation that does not require endocytosis, per se. Point mutations in either the second transmembrane region or second intracellular loop impaired G protein (G(q)) coupling. These receptors exhibited a biphasic pattern of downregulation. The earliest phase of downregulation (0-2 h) was independent of coupling to G(q), but no additional downregulation was observed after 2 h of ANG II exposure in the receptors with impaired coupling to G(q). These data suggest that coupling to G(q) is required for the later phase (2-24 h) of AT(1) receptor downregulation.
1型血管紧张素II(ANG II)(AT(1))受体通过绝对受体数量的下调来响应持续暴露于ANG II的情况。此前一直认为下调涉及内吞作用。本研究假设AT(1)受体下调独立于受体内吞作用或G蛋白偶联发生。与野生型AT(1)受体的65%相比,具有羧基末端缺失的突变型AT(1)受体使放射性配体的内化率<5%。截短的AT(1)受体保留了下调的能力。这些数据表明存在一种不依赖内吞作用本身的AT(1)受体降解替代途径。第二跨膜区或第二细胞内环的点突变损害了G蛋白(G(q))偶联。这些受体表现出双相下调模式。下调的最早阶段(0 - 2小时)独立于与G(q)的偶联,但在与G(q)偶联受损的受体中,ANG II暴露2小时后未观察到进一步下调。这些数据表明,与G(q)的偶联是AT(1)受体下调后期阶段(2 - 24小时)所必需的。